icon-menu
icon-menu

Products

Loratadine, 10 mg tablets

Drug formTablets

ATC categoryAllergology

ATC subcategoryH1 histamine receptor blockers (for systemic use)

Brand nameLoratadine

Generic nameLoratadine

Leaflet in Uzbek: Loratadine

Qualitative and quantitative composition

Each tablet contains:

active ingredient: loratadine – 10 mg;

For a full list of excipients, see section List of excipients.

Posology and method of administration

Adults: one tablet once daily

Paediatric population

Children 6 years of age and older with a body weight greater than 30 kg: One tablet once daily

For appropriate dosing in children younger than 6 years or with body weight of 30 kg or less, there are other formulations more suitable.

The safety and efficacy of Loratadine in children under 2 years of age has not been established. No data are available.

Patients with hepatic impairment

Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10mg every other day is recommended for adults and children weighing more than 30kg.

Patients with renal impairment

No dosage adjustments are required in patients with renal insufficiency.

Elderly

No dosage adjustments are required in the elderly.

 

Method of administration

Oral use. The tablet may be taken without regard to mealtime.

Pharmacological properties

Pharmacotherapeutic group: antihistamines – H1 antagonist.

ATC code: R06AX13.

Pharmaceutical particulars

List of excipients

microcrystalline cellulose

lactose monohydrate

maize starch

sodium starch glycolate

magnesium stearate.

For more detailed information about the drug, click: http://pharm.cals.am/pharm/data/drug_134425/1736329537406.pdf